Are Options Traders Bullish on AKCA?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About AKCA

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, Inc., is a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. Akcea is advancing a mature pipeline of four novel drugs, including volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, all with the potential to treat multiple diseases. All four drugs were discovered by and are being co-developed with Ionis, a leader in antisense therapeutics, and are based on Ionis proprietary antisense technology. The most advanced drug in its pipeline, volanesorsen, is under regulatory review in the U.S., EU and Canada for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL. Akcea is building the infrastructure to commercialize its drugs globally with a focus on lipid specialists as the primary call point. Akcea is located in Cambridge, Massachusetts.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Pharmaceutical Preparation Manufacturing

AKCA is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 274.1 M 2.74063E+08 235 235 0.13% 0.00132897 797 K 797251
DWAQ Invesco DWA NASDAQ Momentum ETF 38.8 M 3.88E+07 100 100 0.75% 0.00752 289 K 288874
EQWS Invesco Russell 2000 Equal Weight ETF 20.0 M 2E+07 1,952 1952 0.03% 0.00027 5 K 5362
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 357 357 0.01% 0.00013965 210 K 209700
FPX First Trust US Equity Opportunities ETF 966.4 M 9.66434E+08 100 100 0.23% 0.0023 2.2 M 2222798
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.22605E+09 224 224 0.37% 0.0037 30.2 M 3.01621E+07
IHE iShares U.S. Pharmaceutical ETF 389.5 M 3.89459E+08 47 47 0.74% 0.0074 2.9 M 2862540
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.5 B 1.65381E+10 3,387 3387 0.0% 0 478 K 477800
IWM iShares Russell 2000 ETF 41.5 B 4.15155E+10 2,023 2023 0.02% 0.0002 8.4 M 8424530
IWO iShares Russell 2000 Growth ETF 8.9 B 8.86114E+09 1,249 1249 0.04% 0.0004 3.5 M 3464860
IWV iShares Russell 3000 ETF 9.5 B 9.52999E+09 2,990 2990 0.0% 0 159 K 159052
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 1,015 1015 0.03% 0.000250455 436 K 435854
UBIO Proshares UltraPro Nasdaq Biotechnology 34.6 M 3.45696E+07 229 229 0.08% 0.00080233 91 K 90810
URTY ProShares UltraPro Russell2000 114.2 M 1.14192E+08 2,034 2034 0.0% 3.54462E-05 14 K 13743
UWM ProShares Ultra Russell2000 163.2 M 1.6324E+08 2,034 2034 0.01% 7.44008E-05 27 K 26547
XPH SPDR S&P Pharmaceuticals ETF 249.5 M 2.4951E+08 47 47 0.81% 0.00805142 2.0 M 2008299

Wait, Before You Leave...